Day Three - ET (Eastern Time, GMT-05:00)
Day Three - ET (Eastern Time, GMT-05:00)
- Susan Stein, Patient Advocacy and Engagement Thought Leader
An organization’s commitment to DEI is imperative for not only retaining qualified and engaged employees but also for improving health outcomes. There are many strategies to bolster DEI efforts, one of which being your patient facing materials.
- Discuss the importance of DEI in your patient education and how it can lead to increased patient engagement and strengthened patient relationships
- Benchmark with colleagues on how to revitalize your material to address cultural misconception and/or mistrust
- Understand the correlation between increased health literacy and reflecting diversity, ethnicity, gender, sexual orientation, family structure and ability level in your design
- Ingrid Jones - Senior Counsel, Pricing & Access and Clinical Diversity, Pfizer
- Lakia Lewis-Latin - Director, Program Management Strategy, Abbvie
With the desire to and everything that can be done to support a drug at launch, it is important to think about how you are defining the problems you need to solve for and the evolution of those challenges and solutions over time. During the session we will talk about the importance of long-term strategy, building HCP behavior and consistency, limiting disruption, “when to say when”, and the importance of field engagement in pulling it all together.
- Farris Ibrahim - Principal, Nuvera Life Science Consulting
- Kim Spalter - Director, Patient Support Services, Bayer
- Lori De Lorenzo - Director, Patient Access Services, Bayer
- Ronald Lacy - Vice President, Product & Innovation, UBC
The alignment of access, legal/compliance and PSP is essential in creating programs that are productive, meaningful and patient centric. Benchmark with colleagues on the best practices that can be instated in each of the respective departments in order to create and foster a relationship that is collaborative, mutualistic and working toward the common goal of helping the patient.
- Amy Wilson - Vice President, Chief Compliance Officer, Esperion Therapeutics
- Jennifer Macauley - Senior Corporate Counsel, Pricing and Access, Pfizer
End your conference with a dynamic conversation surrounding both the current challenges and foreseen opportunities for patient support programs of the future. Take the opportunity as an audience member to ask the experts and receive the answers to your hottest questions.
- Susan Stein, Patient Advocacy and Engagement Thought Leader
- Dana Sun - Associate Director, Patient Engagement & Patient Experience, Otsuka Pharmaceutical Companies (US)